Welcome to our dedicated page for Transcat news (Ticker: TRNS), a resource for investors and traders seeking the latest updates and insights on Transcat stock.
Transcat Inc. provides test, measurement, control and calibration services through Service and Distribution operations. Its Service segment covers calibration capabilities for customers in regulated markets, while its Distribution business markets, sells and rents new and used national and proprietary brand instruments, primarily in North America.
Company news commonly covers quarterly operating results, service organic growth, rental-driven distribution trends, acquisitions that expand calibration capacity and geography, and executive succession or compensation actions. Recent acquisition activity has added calibration laboratories in New England and Costa Rica, extending the company’s service footprint into Latin America.
Transcat, Inc. (Nasdaq: TRNS) has acquired substantially all assets of BioTek Services, Inc. for $3.5 million, effective December 16, 2020. BioTek, based in Richmond, VA, specializes in laboratory instrument calibration and certification, generating approximately $2.1 million in annual revenue. This acquisition aligns with Transcat's growth strategy, enhancing its Life Science division and expanding market reach, particularly in the pipettes market. The integration of BioTek's capabilities is expected to drive growth, leveraging previous acquisitions for a stronger national presence.
Transcat, Inc. (Nasdaq: TRNS) has appointed Mark A. Doheny as its new Chief Financial Officer, succeeding Michael J. Tschiderer, who will retire at the year's end. Doheny brings over 20 years of financial management experience, including roles at Wheelabrator Technologies and Eaton Corporation, focusing on M&A and strategic planning.
This leadership change aims to accelerate Transcat's growth strategy and enhance profitability, particularly in its calibration service business. The Company continues to position itself as a leader in providing calibration and inspection services across regulated industries.
Transcat, Inc. (Nasdaq: TRNS) reported its second-quarter fiscal 2021 results, revealing a 4.5% increase in Service revenue to $24.6 million and a 10% rise in gross profit to $11.5 million. The Service segment achieved a gross margin of 32.2%, its second-highest ever. However, Distribution sales fell by 6.6% to $17.1 million, impacted by the COVID-19 pandemic. Overall revenue saw a minor decline of 0.4%. The company generated $12.5 million in cash from operations, funding debt repayment and technology investments, while net income dropped by 14.9% to $2 million. Outlook remains cautiously optimistic.
Transcat, Inc. (Nasdaq: TRNS) will release its second quarter fiscal year 2021 results after markets close on October 27, 2020. A conference call is scheduled for October 28, 2020, at 11:00 a.m. ET, where financial and operational results will be discussed along with corporate strategy. The call will include a question-and-answer session. Transcat provides accredited calibration, repair, and inspection services across various industries, including Life Sciences, aerospace, and energy. The company aims to drive organic growth and expand its calibration market through acquisitions and investments.